Benjamin F. Edwards & Company, Inc. Twist Bioscience Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 17,166 shares of TWST stock, worth $520,644. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,166
Previous 308
5473.38%
Holding current value
$520,644
Previous $11,000
7590.91%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TWST
# of Institutions
284Shares Held
70.1MCall Options Held
73.4KPut Options Held
43.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.24MShares$189 Million2.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$178 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.85MShares$177 Million0.4% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$165 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.81MShares$115 Million0.46% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.71B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...